Pura Vida Investments, LLC Puma Biotechnology, Inc. Call Options Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$12.3 - $35.76 $227,550 - $661,560	-18,500 Closed	0 $0
Q1 2019 Feb 12, 2021	BUY	$20.77 - $42.37 $380,402 - $776,006	18,315 Added 9900.0%	18,500 $718,000
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $2,014 - $4,109	97 Added 110.23%	185 $37,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $499,983 - $1.16 Million	-24,912 Reduced 99.65%	88 $1,000
Q3 2017 Nov 17, 2017	SELL	$72.0 - $119.75 $1.8 Million - $2.99 Million	-25,000 Reduced 50.0%	25,000 $554 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $3.6 Million - $5.99 Million	50,000	50,000 $831 Million

30.5M

73.5K

18.5K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $118M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.